share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

週四盤後交易時段,12只醫療保健股走勢
Benzinga ·  2023/10/27 05:31

Gainers

獲勝者

  • CVRx (NASDAQ:CVRX) stock moved upwards by 48.0% to $19.0 during Thursday's after-market session. The company's market cap stands at $394.3 million. As per the news, the Q3 earnings report came out today.
  • SeaStar Medical Holding (NASDAQ:ICU) stock increased by 32.57% to $1.05. At the close, SeaStar Medical Holding's trading volume reached 5.3 million shares. This is 40.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $20.4 million.
  • Eargo (NASDAQ:EAR) shares moved upwards by 24.37% to $1.99. At the close, Eargo's trading volume reached 505.1K shares. This is 2469.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $41.2 million.
  • DexCom (NASDAQ:DXCM) stock moved upwards by 14.69% to $93.01. DexCom's trading volume hit 598.8K shares by close, accounting for 13.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $36.0 billion. The company's, Q3 earnings came out today.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 13.08% to $2.68. The company's market cap stands at $1.5 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) stock increased by 12.96% to $0.12. Trading volume for this security closed at 14.1 million, accounting for 605.5% of its average full-day volume over the last 100 days. The company's market cap stands at $27.6 million.
  • cvRX 納斯達克股票代碼:CVRX)在週四的盤後交易時段上漲了48.0%,至19.0美元。該公司的市值爲3.943億美元。根據消息,第三季度收益報告今天發佈。
  • 海星醫療控股公司 納斯達克股票代碼:ICU)股價上漲32.57%,至1.05美元。收盤時,SeaStar Medical Holding的交易量達到530萬股。這是其過去 100 天平均交易量的40.9%。他們流通股的市值爲2,040萬美元。
  • Eargo 納斯達克股票代碼:EAR)股價上漲24.37%,至1.99美元。收盤時,Eargo的交易量達到50.51萬股。這是其過去100天平均交易量的2469.3%。他們流通股的市值爲4,120萬美元。
  • DexCom 納斯達克股票代碼:DXCM)股價上漲14.69%,至93.01美元。德克斯康的交易量收盤時達到598.8萬股,佔其過去100天平均交易量的13.0%。他們流通股的市值爲360億美元。該公司今天公佈了第三季度業績。
  • 中國蘇軒堂藥業 納斯達克股票代碼:SXTC)股價上漲13.08%,至2.68美元。該公司的市值爲150萬美元。
  • 阿拉諾斯療法 納斯達克股票代碼:TCRT)股價上漲12.96%,至0.12美元。該證券的交易量收於1,410萬,佔其過去100天平均全日交易量的605.5%。該公司的市值爲2760萬美元。

Losers

失敗者

  • TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 31.5% to $0.28 during Thursday's after-market session. Trading volume for this security closed at 15.4 million, accounting for 333.3% of its average full-day volume over the last 100 days. The company's market cap stands at $3.4 million.
  • PTC Therapeutics (NASDAQ:PTCT) stock declined by 15.75% to $20.18. PTC Therapeutics's trading volume hit 80.0K shares by close, accounting for 6.8% of its average volume over the last 100 days. The company's market cap stands at $1.5 billion. The company's, Q3 earnings came out today.
  • ContraFect (NASDAQ:CFRX) stock declined by 15.25% to $0.26. The company's market cap stands at $1.4 million.
  • Bio-Rad Laboratories (NYSE:BIO) shares decreased by 10.82% to $260.0. The market value of their outstanding shares is at $7.5 billion. As per the news, the Q3 earnings report came out today.
  • Day One Biopharmaceutical (NASDAQ:DAWN) shares decreased by 7.31% to $9.34. The company's market cap stands at $812.6 million.
  • Processa Pharma (NASDAQ:PCSA) shares declined by 7.13% to $0.3. This security traded at a volume of 90.2K shares come close, making up 4.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.3 million. See Also:
  • TransCode 治療學 納斯達克股票代碼:RNAZ)在週四的盤後交易時段下跌了31.5%,至0.28美元。該證券的交易量收於1,540萬筆,佔其過去100天平均全日交易量的333.3%。該公司的市值爲340萬美元。
  • PTC 療法 納斯達克股票代碼:PTCT)股價下跌15.75%,至20.18美元。PTC Therapeutics的交易量收盤時達到80.0萬股,佔其過去100天平均交易量的6.8%。該公司的市值爲15億美元。該公司今天公佈了第三季度業績。
  • 對比 納斯達克股票代碼:CFRX)股價下跌15.25%,至0.26美元。該公司的市值爲140萬美元。
  • 生物射線實驗室 紐約證券交易所代碼:BIO)股價下跌10.82%,至260.0美元。他們流通股的市值爲75億美元。根據消息,第三季度收益報告今天發佈。
  • 第一天生物製藥 納斯達克股票代碼:DAWN)股價下跌7.31%,至9.34美元。該公司的市值爲8.126億美元。
  • 過程製藥 納斯達克股票代碼:PCSA)股價下跌7.13%,至0.3美元。該證券的交易量接近90.2萬股,佔過去100天平均交易量的4.8%。他們流通股的市值爲730萬美元。 另請參閱:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閱。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論